United Therapeutics CorporationUTHRNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$1.38B
↑ 75% above average
Average (9y)
$788.45M
Historical baseline
Range
High:$1.38B
Low:$-187.60M
CAGR
+7.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $1.38B | +16.2% |
| 2023 | $1.18B | +20.9% |
| 2022 | $979.70M | +76.2% |
| 2021 | $555.90M | -6.4% |
| 2020 | $593.60M | +416.4% |
| 2019 | $-187.60M | -123.3% |
| 2018 | $805.40M | -1.2% |
| 2017 | $814.90M | -23.2% |
| 2016 | $1.06B | +51.9% |
| 2015 | $699.01M | - |